Back to search
Coronary Allograft Vasculopathy (CAV)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Coronary Allograft Vasculopathy (CAV) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Coronary Allograft Vasculopathy (CAV) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Coronary allograft vasculopathy (CAV) is diffusely accelerated atherosclerosis of a transplanted heart. Evolocumab (Repatha) is an FDA-approved drug for lowerin…
Many patients with end-stage heart failure, a condition in which the heart fails to pump enough blood to support the body's other organs, are fortunate enough t…